Protocol Ledger

Biopharma Industry · Consolidated Sponsor Hub

Ultragenyx Pharmaceutical: Clinical Trials & FDA Approval Profile

Ultragenyx Pharmaceutical (Global / Institutional) sponsors 17 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 8 active protocols (2 recruiting now), 3 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)35.3%
Median Closed Enrollment vs National (145 pts)54 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Ultragenyx Pharmaceutical
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)17
Active Pipeline (Recruiting Now)8 (2)
Completed vs Stopped Early3 / 6 (35.3%)
Median Closed Actual Enrollment54 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Ultragenyx Pharmaceutical
Hospital Research SiteLocationShared Protocols
Children's Hospital ColoradoAurora, CO4
Vanderbilt University Medical CenterNashville, TN3
UCLA Health and Jonsson Comprehensive Cancer CenterLos Angeles, CA3

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Ultragenyx Pharmaceutical
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT05345171Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) DeficiencyPhase IIIACTIVE NOT RECRUITING

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Ultragenyx Pharmaceutical across sibling Meru public-data platforms.

Explore interactive annual charts and M&A subsidiary rollups in the Ultragenyx Pharmaceutical Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI